(Q44655656)

English

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

internal medicine

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

author name string

J. S. Christiansen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

J. A. Vaz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

Z. Metelko

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

M. Bogoev

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

I. Dedov

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617231

1 April 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14617231

1 April 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1463-1326.2003.00300.x

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1463-1326.2003.00300.x/fullpdf

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

446-454

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00300.X

21 January 2018

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.37.1.60

Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIACARE.7.2.147

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes

6

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

12

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

14

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

15

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

The utility of glycated hemoglobin in identification of impaired glucose tolerance

18

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus

19

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Postprandial hyperglycaemic state: importance and consequences

20

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Hyperglycemia and microvascular and macrovascular disease in diabetes

21

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

24

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

27

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

28

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

29

1 reference

10.1046/J.1463-1326.2003.00300.X

https://api.crossref.org/works/10.1046/J.1463-1326.2003.00300.X

1 April 2024

Identifiers

10.1046/J.1463-1326.2003.00300.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44655656&oldid=2118757341"